In this webinar, our guests will offer a presentation for chaplains on  psychedelic medicines, with a particular focus on psychedelics'  potential application for end of life and palliative care (EOLPC)  patients. The presentation will include an overview of data on  psilocybin therapy for psychological distress in EOLPC.

Chaplains  served as study clinicians in a recent clinical trial of psilocybin  therapy at UCSF, and chaplains are now being included in more trials  with EOLPC populations both at Dana-Farber Cancer Institute and Emory  Healthcare. This presentation looks toward a future of greater openness  to, and recognition of the benefits of, working with chaplains as the  field of psychedelic medicine continues to grow.